Current Oncology Reports

Papers
(The median citation count of Current Oncology Reports is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer170
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review112
Brain Prehabilitation for Oncologic Surgery98
Surgical Management of Melanoma: Advances and Updates81
Immunotherapy in Biliary Tract Cancers: Where Are We?62
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas51
New Developments in VHL-Associated Neuroendocrine Neoplasms50
NRG1 Fusions: The New Kid on the Block49
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review48
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting45
The Microbiome in Advanced Melanoma: Where Are We Now?45
Surgical Stress and Cancer Progression: New Findings and Future Perspectives43
Head and Neck Mucosal Melanoma: Where Are We Now?39
Current Trends and Challenges of Microbiome Research in Prostate Cancer39
AXL Inhibitors: Status of Clinical Development38
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan38
Cellular Therapy in NSCLC: Between Myth and Reality38
The Difficult Airway in Patients with Cancer37
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients37
An Overview of Angiogenesis in Bladder Cancer36
Appendiceal Neuroendocrine Neoplasms: an Update for 202334
Targeting the PI3K Pathway in Gynecologic Malignancies33
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review32
Proton Therapy in The Treatment of Head And Neck Cancers- Review30
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours30
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?29
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations28
CAR-T Therapies in Solid Tumors: Opportunities and Challenges28
Geographical Disparities in Colorectal Cancer in Canada: A Review27
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews26
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations26
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer26
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)24
Development of Effective Siglec-9 Antibodies Against Cancer24
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question24
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials23
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review23
Surgery for Recurrent Epithelial Ovarian Cancer23
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing23
Vascular Inflammation, Cancer, and Cardiovascular Diseases23
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets22
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma22
Current Management of Neuroendocrine Tumour Liver Metastases22
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions22
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?21
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging21
Current Diagnostic Tools for Breast Cancer-Related Lymphedema21
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer20
Management of Peripheral T-cell Lymphomas and the Role of Transplant20
Elderly Rectal Cancer: An Updated Review20
Small Cell and Other Rare Histologic Types of Cervical Cancer20
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review19
Multimodality Therapies for Localized Prostate Cancer19
Current Status on Management of Primary Plasma Cell Leukemia19
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights19
History of Leukemia, Revisited19
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers18
Intratumoral Immunotherapy: Is It Ready for Prime Time?18
Epidemiology of Cancer in Older Adults: A Systematic Review18
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review18
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions17
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma17
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis17
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment17
Return to Intended Oncological Therapy: State of the Art and Perspectives17
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy17
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives17
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade17
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development17
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours17
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer16
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?16
CDK4/6 inhibitors: The Devil is in the Detail16
Racial Disparities in Breast Cancer: from Detection to Treatment16
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL16
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas16
Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes15
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine15
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer15
Epidemiology of cancer in older adults: a systematic review of age-related differences in solid malignancies treatment15
All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations15
Cardio-Oncology in Childhood: State of the Art15
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway15
Advances in Treatment of Waldenström Macroglobulinemia15
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer15
CAR T-cell Therapy for Central Nervous System Lymphoma15
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism14
Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from Taiwan14
Surviving Burnout as an Oncologist14
New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors14
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science14
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis14
Intracranial Germinomas: Diagnosis, Pathogenesis, Clinical Presentation, and Management14
Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab14
Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers14
Fertility-Sparing and Less Radical Surgery for Cervical Cancer14
Pelvic Floor Therapy and Initial Interventions for Pelvic Floor Dysfunction in Gynecologic Malignancies14
Integrative Geriatric Oncology: A Review of Current Practices14
Percutaneous Ablation of T1b Renal Cell Carcinoma: An Overview13
Exercise as Medicine in Cardio-Oncology: Reducing Health Disparities in Hispanic and Latina Breast Cancer Survivors13
Defining The Role for Hormone Therapy in Biochemically Recurrent Prostate Cancer: What Counts as a Win for Patients?13
Perioperative Blood Transfusions and Cancer Progression: A Narrative Review12
Correction to: Postmastectomy Functional Impairments12
Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?12
An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism12
BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach12
Oligometastatic Esophagogastric Cancer: Does It Exist and How Do We Treat It?12
Cold-antibody Autoimmune Hemolytic Anemia: its Association with Neoplastic Disease and Impact on Therapy12
Clinical Applications and Advancements of Positron Emission Tomography/Computed Tomography in Cardio-Oncology: A Comprehensive Literature Review and Emerging Perspectives12
Post-acute Care Needs and Benefits of Inpatient Rehabilitation Care for the Oncology Patient12
Oral Complications and Management Strategies for Cancer Patients: Principles of Supportive Oncology in Dentistry12
Germline Mutations and Ancestry in Prostate Cancer12
Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions12
Adjuvant Therapy in Node-Positive Endometrial Cancer: A Focus on Chemotherapy12
Perceptions, Knowledge, and Attitudes of General Population About Prostate Cancer-Associated Risk Factors: A Systematic Review of Qualitative Studies Focusing on Lifestyle12
Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm12
The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies12
Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science12
Melanoma in Pediatric and Young Adult Patients11
Integrative Oncology Approaches to Reduce Recurrence of Disease and Improve Survival11
Effect of Post-diagnosis Physical Activity on Breast Cancer Recurrence: a Systematic Review and Meta-analysis11
Toxicities from BRAF and MEK Inhibitors: Strategies to Maximize Therapeutic Success11
ChatGPT in Oncology Diagnosis and Treatment: Applications, Legal and Ethical Challenges11
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths11
Evolving Strategies in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Esophagogastric Adenocarcinoma11
Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors11
Prostate Cancer, Pathophysiology and Recent Developments in Management: A Narrative Review11
Beneath the Surface: The Emerging Role of Ultra-Processed Foods in Obesity-Related Cancer11
Hairy Cell Leukemia: Where Are We in 2023?11
Radiation and Melanoma: Where Are We Now?11
Novel Insights of Anti-EGFR Therapy in HNSCC: Combined with Immunotherapy or Not?11
Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy11
The Microbiome’s Influence on Head and Neck Cancers11
Asparaginase: How to Better Manage Toxicities in Adults11
Cell-free Tumor DNA: a Promising Technology for Diagnosis, Surveillance and Therapeutic Decision in Urothelial Carcinoma of the Bladder10
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)10
Targeted Therapy for Melanomas Without BRAF V600 Mutation10
Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma10
Postoperative Delirium and Neurocognitive Disorders: Updates for Providers Caring for Cancer Patients10
Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology10
Correction to: Past, Present, and Future Therapeutic Strategies for NF‑1‑Associated Tumors10
Liver Cancer Etiology: Old Issues and New Perspectives10
Current Issues in Fertility Preservation Among Pediatric and Adolescent Cancer Patients10
Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors10
Update on Percutaneous Ablation for Sarcoma10
Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges10
Cardiac Arrhythmias in Oncological Patients—Epidemiology, Risk Factors, and Management within the Context of the New ESC 2022 Guidelines10
Immune-Related Adverse Events in Patients with Lung Cancer9
Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances9
Immune Checkpoint Inhibitors in Geriatric Oncology9
Novel Clinical PET Tracers in the Pipeline for Melanoma9
Translocations and Gene Fusions in Sinonasal Malignancies9
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer9
Recent Progress in Mind–Body Therapies in Cancer Care9
Current Trends and Challenges of Microbiome Research in Bladder Cancer9
Older Patients with Lung Cancer: a Summary of Seminal Contributions to Optimal Patient Care9
Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment9
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned9
Ablation of Kidney Tumors in Patients with Substantial Kidney Impairment: Current Status9
Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review9
De-escalation for Human Papillomavirus-Positive Oropharyngeal Cancer: A Look at the Prospective Evidence9
Chemotherapy-Induced Peripheral Neuropathy: Diagnosis, Agents, General Clinical Presentation, and Treatments9
The Evolving Therapeutic Landscape for Malignant Pleural Mesothelioma9
Non-squamous Cancers of the Larynx9
Advances in Radiation Oncology in Soft Tissue Sarcoma9
Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape9
Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment9
Existing Health Inequities in the Treatment of Advanced and Metastatic Cancers9
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis8
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?8
Metronomic Chemotherapy in Elderly Patients8
Approach to the Older Patient with Acute Myeloid Leukemia8
Aromatase Inhibitor Musculoskeletal Syndrome and Bone Loss: a Review of the Current Literature8
Molecular Testing in Gliomas: What is Necessary in Routine Clinical Practice?8
Telehealth Utilization in Neuro-Oncology: Commentary on a Single Institution Experience After the COVID-19 Pandemic8
Current Status of Immunotherapy in Management of Small Bowel Neuroendocrine Tumors8
Oncolytic Viruses and Cancer Immunotherapy8
Surgery in the Era of Immunotherapy for Advanced Head and Neck Non-melanoma Skin Cancer8
Cardiotoxicities of Non-Chemotherapeutic Metastatic Breast Cancer Treatments8
Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship8
Addressing Residual Disease in HER2-Positive and Triple-Negative Breast Cancer: What Is Next?8
PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go?8
Emerging Therapeutic Targets of Neuroendocrine Prostate Cancer8
Percutaneous Management of Breast Cancer: a Systematic Review8
0.24271893501282